欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2481/001
药品名称Kajodan 65 mg
活性成分
    • Iodine potassium salt 65.0 mg
剂型Tablet
上市许可持有人G.L. Pharma GmbH Schlossplatz 1 8502 Lannach Austria
参考成员国 - 产品名称Netherlands (NL)
Kajodan 65 mg tabletten
互认成员国 - 产品名称
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Portugal (PT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Potassium iodide G.L. Pharma 65 mg tabletes
    • Lithuania (LT)
      Potassium iodide G.L. Pharma 65 mg tabletės
    • Estonia (EE)
      POTASSIUM IODIDE G.L. PHARMA
    • Bulgaria (BG)
      Ptassium iodide G.L.Pharma
    • Cyprus (CY)
      POTASSIUM IODIDE TABS
    • Czechia (CZ)
      Jodid draselný G.L. Pharma 65 mg tablety
    • Romania (RO)
      Iodură de potasiu G.L. Pharma 65 mg comprimate
    • Slovakia (SK)
      Jodid draselný G.L. Pharma 65 mg tablety
    • Slovenia (SI)
      Kalijev jodid G.L. Pharma 65 mg tablete
    • Malta (MT)
      Potassium iodide G.L. Pharma 65 mg tablets
许可日期2012/04/05
最近更新日期2024/02/26
药物ATC编码
    • V03AB21 potassium iodide
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase